Top 25 Medical Angel Investors in France in October 2024
A list of 25 angel investors that invest in Medical startups based in France. We rank investors based on the number of investments they made in Medical companies from France. We update this investor list every month.Top 25 Medical Angel Investors in France in October 2024
Investor | Medical France investments |
---|---|
Bernard Majoie | 3 |
Pierre Kosciusko-Morizet | 2 |
Daniel Caille | 2 |
André-Jacques Auberton-Hervé | 2 |
Nicolas Dessaigne | 2 |
Guillaume Richard | 2 |
Nicolas Douay | 2 |
Bertrand Jelensperger | 2 |
André-Jacques Auberton-Hervé | 2 |
Olivier Occelli | 1 |
Antoine Freysz | 1 |
Guillaume Amblard | 1 |
Jean-Paul Kress | 1 |
Rémi Gaston- Dreyfus | 1 |
Philippe du Mesnil | 1 |
Geoffrey Duyk | 1 |
Alain Tingaud | 1 |
Flavien Kulawik | 1 |
Giorgio Anania | 1 |
Yann Fleureau | 1 |
Bernard Chauvin | 1 |
Victor Douce | 1 |
Pierre Krings | 1 |
Pierre Olivier Goineau | 1 |
Dominique Vidal | 1 |
Bernard Majoie - President @ Fournier-Majoie
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Pierre Kosciusko-Morizet is an Internet entrepreneur, founder and former CEO of French e-commerce pioneer PriceMinister. After he sold Priceminister to Japanese internet giant Rakuten in 2010 for $350m, he became Rakuten Europe COO. He left Rakuten in 2014 so as to concentrate on his investments and new project.Pierre Kosciusko-Morizet is agraduate of the famous HEC Paris business school, where he studied entrepreneurship. He launched his first company, Visualis SA (a consultancy for the distribution sector), while still studying at HEC, with a €10,000 student loan. After graduating from HEC, Kosciusko-Morizet moved to the United States and became a manager in the marketing department of Finance Capital One, an internet-based credit card company. There he managed a team of 60 analysts, and specialised in the online credit and banking market.It was there that Kosciusko-Morizet saw a gap in the market. While websites existed in the United States linking buyers and sellers online, there was no equivalent site in France. He resigned from Finance Capital One and returned to France two weeks later to work on what would become PriceMinister with Pierre Krings, Olivier Mathiot, Nathalie Maurin and Justin Ziegler. In 2001 Priceminister launched and has grown into one of the largest and most successful e-commerce companies in France, currently employing around 200 passionate and dedicated staff.Pierre Kosciusko-Morizet is a former President of the ACSEL (Association of the Digital Economy) and of the ASIC (Association of Internet Community Services), and Chairman and main investor of the Strategic Committee of ISAI, the “French internet entrepreneurs fund”, that raised over $100m. In 2010 Kosciusko-Morizet published an autobiographical book which details the story of PriceMinister.
Show more
Investment focus
- Health Care, Internet, E-Commerce
- Seed, Series A, Angel
- France, Israel
Portfolio highlights
- youzd — youzd is an e-commerce platform for second-hand furniture, electronics, and decoration products.
- PowerZ — Tailored for kids ages 6 and up - learn Math, English, Geography, History, and Music in a universe that adapts to your level!
- Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
Daniel Caille
Show more
Investment focus
- Elderly, Medical, Software
- Series A, Pre-Seed, Funding Round
- France
Portfolio highlights
- HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
- Medylink —
- CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more
Investment focus
- Medical, Biotechnology
- Seed, Series A
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Nicolas is a firm believer of “culture-first” companies and am focused on building just that at Algolia where team empowerment is how they accomplish their goals. Prior to co-founding Algolia with Julien, he spent over 12 years working on information retrieval at Exalead and Thales.At Algolia they believe every website and app deserves greatsearch! they offer a hosted Search API that helps developers deliver an instant and relevant search experience. We’ve seen that search is a great touch point to optimize – they regularly see double digit increases in engagement on sites when they improve their search UX.When they founded Algolia in 2012 it was originally going to be a local SDK for mobile app search. They changed direction and realized that they needed to offer search as a hosted SaaS service, but it was those early mobile optimizations that gave us their unique advantage. They are one of the few search solutions that has been developed from scratch, and they never would have gone that direction if they hadn’t originally been focused on mobile search.His focus has been first and foremost on making Algolia a great place to work. They have a unique culture here that values ownership as its pillar. They want to create a company where every team member takes initiative, gets out of their comfort zone, is empowered to make decisions; in short: be free to be their best.He is recently spoken at SaaStock on the challenges of running a company based in both Paris and San Francisco. His priority lately has been on scaling their growth and ramping up their team size.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Pre-Seed, Seed, Series A
- United States, France, Germany
Portfolio highlights
- Arcjet — Arcjet helps developers protect their apps in just a few lines of code. Implement rate limiting, bot protection, email validation, and defense against common attacks.
- Kestra Technologies — Use declarative language to build simpler, faster, scalable and flexible data pipelines
- Graneet — Graneet is a Digital Site Manager Assistant that is designed to help Construction Project Managers better track the financials and administrative processes of their projects (invoices, expenses, payments...).
Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.
Show more
Investment focus
- Medical, Software, Health Care
- Pre-Seed, Series A
- France
Portfolio highlights
- HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Previously cofounder @ Keldoc - currently early stage investor @ Better Angle
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Pre-Seed, Angel
- France, United Kingdom, Mauritius
Portfolio highlights
- Bealy health — Bealy is a prevention and health solution dedicated to employees to improve their daily health and well-being.
- Djamo — Djamo is a Provider of financial applications to allow customers to use their cards with zero fees in a wide range of services.
- underdog — underdog is a simplified & refurbished household appliances.
Bertrand Jelensperger is the Co-Founder and Advisory Board at TheFork.
Show more
Investment focus
- Apps, Organic Food, Software
- Seed, Series A, Angel
- France, Spain, Belgium
Portfolio highlights
- Malou — Malou offers food marketing and digital marketing solutions for restaurants. The company also offers content management, restaurant marketing, reputation management, presence management, and SEO solutions.
- Kiliba — 100% automated emailing platform: design of html templates in your colours, sending of personalised emails, marketing automation workflows, enriched CRM
- Neptune Elements — Neptune Elements offerFrench seaweed of controlled origin, with exceptional taste and culture.
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more
Investment focus
- Medical, Biotechnology
- Seed, Series A
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Olivier started his career in 1998 as a Production and Quality Manager for DeliFrance, managing over 50 employees in three shifts, 7 days a week.In 2001, he became Sales Director for IMDS, a leading hosting and IT solutions provider in Western Europe. In 2007, Olivier founded NaturaBuy, a marketplace dedicated to outdoor sports, hunting andfishing, addressing a €2.5 billion market in France. NaturaBuy is now the leading marketplace of its sector, powering tens of thousands of transactions each month and €60 million in annual Transaction Volume.Olivier has backed some the most successful Kerala startups from their creation, such as Doctolib, Malt, admo.tv and Privateaser.Olivier holds a MSc in Engineering.Past and current Boards: Kerala Ventures, NaturaBuy (as CEO)
Show more
Investment focus
- Medical, Hospital, Health Care
- Seed
- France
Portfolio highlights
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
After launching his first venture in 2000 (exited in 2002), Antoine joined the Travelocity / Lastminute group as Sales Director and then becoming COO. At that time, he directly managed 200 employees, including 50 salespeople.In 2009, he cofounded the “Startup Studio” Otium with Pierre-Edouard Sterin, Smartbox’s founder. Antoine built thefounding team, hiring Stanislas Niox-Château and Philippe de Chanville (5 years later, Stan will found Doctolib and Philippe ManoMano). As Otium CEO, Antoine conducted the acquisition of LaFourchette in 2009, led Lafourchette’s Board for 6 years (the startup grew from 3 to 250 salaries across 4 markets) and conducted the exit process to TripAdvisor in May 2014.Antoine cofounded a total of 6 “Otium” startups, among others Balinea, the leading platform for beauty institute bookings, and Weekendesk, an OTA for weekends generating above €100 million in Transaction Volume in 5 countries.Antoine graduated from HEC Paris.
Show more
Investment focus
- SaaS, Video, Medical
- Seed, Series A
- France
Portfolio highlights
- RockFi — RockFi is a private management company offering wealth management services.
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
- PlayPlay — Create professional videos and engage your audience with PlayPlay, the collaborative online video maker. No editing skills required. Try it free for 7 days.
Guillaume Amblard
Show more
Investment focus
- Banking, Health Care, Environmental Consulting
- Seed, Funding Round, Pre-Seed
- France
Portfolio highlights
- Keewe — Simply take part in the ecological transition thanks to your banking transactions and our exchange platform which acts in favour of the planet.
- Cosmian — We offer a unique, comprehensive data protection suite powered by next-generation cryptography to secure your data in in use.
- Scienta Lab — Redefining precision immunology
Jean-Paul Kress
Show more
Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Rémi Gaston- Dreyfus
Show more
Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Philippe du Mesnil, a private investor
Show more
Investment focus
- Medical, Manufacturing, Medical Device
- Funding Round
- France
Portfolio highlights
- Ilasis — Ilasis is an innovative player in medical devices by applying frugal innovation to the challenges of ophthalmology. We designed Helix, a patented and unique laser solution, the first femtosecond laser of its kind, dedicated to capsulorhexis for cataract surgery
Dr. Geoffrey Duyk was a member of the Board from May 2006 through May 2011, and re-joined the Board in May 2012. Dr. Duyk is a partner of TPG Growth, LLC, an affiliate of TPG Biotechnology Partners II, L.P.Previously, he served on the board of directors and was President of Research and Development at Exelixis, Inc., a biopharmaceutical companyfocusing on drug discovery, from 1996 to 2003.Prior to Exelixis, Dr. Duyk was Vice President of Genomics and one of the founding scientific staff at Millennium Pharmaceuticals, from 1993 to 1996.Before that, Dr. Duyk was an Assistant Professor at Harvard Medical School in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute.Dr. Duyk currently serves on the boards of directors of several private companies and the non-profit Wesleyan University Board of Trustees. He served on the board of directors of Agria Corporation from August 2007 to May 2009, Cardiovascular Systems, Inc. (formerly Replidyne, Inc.) from 2004 to February 2009, Exelixis, Inc. from 1996 to 2003. Dr. Duyk holds a Bachelor of Arts degree in Biology from Wesleyan University and Doctor of Philosophy and Medicine degrees from Case Western Reserve University.
Show more
Investment focus
- Biotechnology, Medical, Chemical
- Series B, Series A, Series C
- United States, Japan, France
Portfolio highlights
- DNAnexus — The world's most secure & trusted biomedical cloud platform that accelerates clinical and scientific discovery with the potential to improve patient lives.
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
- Aerie Pharmaceuticals — Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.
Alain Tingaud is a Founder & CEO at Alain Tingaud Innovations.
Show more
Investment focus
- Software, E-Commerce, Cryptocurrency
- Pre-Seed, Seed
- France, Luxembourg
Portfolio highlights
- Gonuggets — We help digitally native brands to grow their e-commerce revenue on marketplaces such as Amazon and D2C across EMEA.
- MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
- Trendex — Mobile App
Flavien Kulawik
Show more
Investment focus
- Health Care, Artificial Intelligence, SaaS
- Seed, Funding Round, Series A
- France, United Kingdom
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Giorgio has spent more than 30 years in senior management at high-technology companies, from start-up ventures to international public companies, and has led two successful IPOs. He is chairman of Cube Optics AG and vice president of the executive board at Photonics21.Previously, Giorgio was CEO of Bookham, now Oclaro, which he grew from astart-up into a quarter-billion-dollar NASDAQ-listed public company. He also served as the vice president of sales, finance and business development for Flamel Technologies.Prior to that, he was the founder and general manager of the Miniplex DSL Business Unit at Raychem and strategy consultant at Booz Allen.He has a M.A. degree in physics from Oxford University and a Ph.D. in thermonuclear fusion from Princeton University.
Show more
Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — Covid-19 Vaccine Laboratory - Linkinvax - Leading the Revolution - The result of the association of French scientists and entrepreneurs, LinKinVax accelerates the development of safe, effective and scalable vaccines.
Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.
Show more
Investment focus
- Health Care, Medical Device, Artificial Intelligence
- Series A, Series B
- France
Portfolio highlights
- Sonio — Sonio is an artificial intelligence for fetal ultrasound, helping practitioners analyse and diagnose congenital malformations.
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Bernard Chauvin, a renowned authority in the field of ophthalmology, sits on the company's Board of Directors.March 12, 2013 – EyeTechCare SA, has secured a third round of funding amounting to EUR 10 million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors which alsocontributed to this round of funding: the capital investment company Omnes Capital (formerly Crédit Agricole Private Equity) and the Lyon-based insurer SHAM. Bernard Chauvin is a physician specializing in ophthalmology. He headed the Laboratoires Chauvin for 27 years (until its acquisition by Bausch & Lomb), prior to joining Neurotech, a French biotechnology company where he served as Chief Executive Officer until 2004. Since then, he has taken an active role as a director in the development of a number of pharmaceutical and biotechnology companies.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A, Series C
- France
Portfolio highlights
- EyeTechCare — EyeTechCare has developed a new medical device called EyeOP1. This leading edge technology device is the result of several years of joint research with INSERM which has led to the development of a treatment method using High Intensity Focused Ultrasound (HIFU).EyeOP1 is an ultrasound device which offers a non-invasive treatment for refractoryglaucoma. This new method is extremely accurate, simple and only takes one minute.
- Ciliatech — Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects.
Victor Douce
Show more
Investment focus
- Health Care, FinTech, Medical
- Series C, Funding Round, Pre-Seed
- United States, France, Germany
Portfolio highlights
- Magnisense — Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires
- The EVERY Company — Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.
- Terran Biosciences — Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
Pierre Krings is the founder of Price Minister.
Show more
Investment focus
- Rental, Health Care, Information Technology
- Funding Round, Seed, Series A
- France
Portfolio highlights
- Jam — Jam uses AI and process optimization to assist students in their daily lives.
- Tracktor — Tracktor is a rental platform for construction workers, enabling them to rent out or borrow construction equipment in a few clicks.
- Renovation Man — Renovation Man is a provider of services intended to revolutionize the world of renovation work.
Pierre Olivier Goineau - President @ Neuronax
Show more
Investment focus
- Medical, Biopharma, Health Care
- Funding Round
- France
Portfolio highlights
- Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
Dominique Vidal is a Venture Partner at Index Ventures.
Show more
Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Seed
- France, United States, United Kingdom
Portfolio highlights
- Koyeb — Koyeb is a developer-friendly serverless platform to deploy apps globally. No-ops, servers, and infrastructure management.
- Leavy.co — Leavy.co allows for anyone to live wherever they like, no matter how much they make, even for a day. Covid has turned our idea of work and travel upside down. It’s now all about mobility, for a generation who cannot afford it. The platform pays cash to all members willing to share their homes with the community or care for others.
- Gens de Confiance — It is not enough to offer a wide range of products and services, you have to ensure that everyone is reliable. GensDeConfiance fights against online scams and build trust via a super-secured classifieds ad board. Our classifieds are only accessible to people who are endorsed by at least three other members. And if we have to remove someone, wealso remove all his referrers accounts! Therefore, not only we ensure that just the more reliable people can join, but every member is accountable at any time then.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Social Media
Retail
Medical
Financial Services
Email
Infrastructure
Art
Platforms
Wellness
Mobile Advertising
Music
Biotechnology
Mobile
Hospitality
Franchise
Social Network
Fitness
Local
Travel
Internet
Recruiting
Digital Media
Cannabis
Construction
Manufacturing
Wine And Spirits
eSports
Sports
Medical Device
Enterprise Software
Legal
Android
Crowdfunding
CleanTech
Social
Transportation
Automotive
Mobile Apps
InsurTech
Enterprise
Life Science
LGBT
Theatre
Film
SaaS
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Software
Social Impact
Celebrity
Cryptocurrency
Media (entertainment)
Agriculture (agtech)
Blockchain
Facebook
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Morocco
Egypt
Malta
Mali
Malaysia
Hungary
Italy
Ethiopia
Faroe Islands
Algeria
Peru
Ghana
Belgium
Lithuania
Croatia
Myanmar
Lebanon
Kuwait
Cayman Islands
Bulgaria
Cambodia
Israel
Bahrain
Panama
Turkey
Mexico
Kazakhstan
Serbia
Liberia
Jersey
Rwanda
Philippines
El Salvador
Norway
Venezuela
Mauritius
Ukraine
Kenya
Liechtenstein
Portugal
Nicaragua
Dominican Republic
Sierra Leone
Zimbabwe
Sweden
Nigeria
Azerbaijan
Namibia
Iceland
Taiwan
Iraq
Bahamas
United Arab Emirates
Honduras
Senegal
Bolivia
Isle of Man
Luxembourg
Uruguay
Uganda
Albania
Pakistan
Tunisia
San Marino
Slovenia
Zambia
Uzbekistan
Russian Federation
Grenada
Jordan
Romania
Seychelles
Argentina
Bangladesh
Thailand
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Austria
Latvia
Cyprus
Oman
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Angel Investors in France by industry
Crowdfunding
Venture Capital
Fitness
Restaurants
Cryptocurrency
Finance
Video Games
Organic Food
Wine And Spirits
Photography
Education
Wellness
Medical Device
Email
Social Media
Internet
Social Network
Digital Media
Manufacturing
Android
Art
Blockchain
Mobile
Construction
Legal
Sports
Software
Hospitality
Enterprise Software
Music
Travel
InsurTech
Recruiting
Biotechnology
Platforms
FinTech
Consumer
Enterprise
Health Care
EdTech
Energy
Sustainability
Proptech
SaaS
Marketplace
Community
Hardware
Mobile Apps
Retail
Infrastructure
Fashion
Beauty
Web3
B2B
Impact
Food and Beverage
Payments
Artificial intelligence
Financial Services
Real Estate
Publishing
Big Data
Gaming
Medical
Life Science
Transportation
Agriculture (agtech)
Media (entertainment)
Renewable Energy
Climate
Automotive
Biotech